BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25700239)

  • 61. Should Denosumab or Radical Surgery Be Recommended for a Spinal Giant Cell Tumour in a Fertile Female?
    Rajgor HD; James S; Botchu R; Grainger M; Czyz M
    Cureus; 2020 Nov; 12(11):e11526. PubMed ID: 33354470
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Giant cell tumor of the vertebral column.
    Boriani S; Biagini R; Laus M; de Iure F; Campanacci L
    Chir Organi Mov; 1996; 81(3):233-45. PubMed ID: 9009406
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Osteosarcoma of the mobile spine.
    Schwab J; Gasbarrini A; Bandiera S; Boriani L; Amendola L; Picci P; Ferrari S; Boriani S
    Spine (Phila Pa 1976); 2012 Mar; 37(6):E381-6. PubMed ID: 22422440
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Effect of Denosumab and Risk Factors for Recurrence in Spinal Giant Cell Tumors: A Systematic Review and Meta-Analysis.
    Noh SH; Ha Y; Cho PG; Kim KN; Shin DA; Kim SH
    Yonsei Med J; 2022 Sep; 63(9):834-841. PubMed ID: 36031783
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Giant cell tumor of the uterus: case report and response to chemotherapy.
    Skubitz KM; Manivel JC
    BMC Cancer; 2007 Mar; 7():46. PubMed ID: 17359524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Response of Aneurysmal Bone Cyst to Denosumab.
    Skubitz KM; Peltola JC; Santos ER; Cheng EY
    Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Giant cell tumor of the cervical spine treated by carbon ion radiotherapy: A case report.
    Sakuda T; Furuta T; Okimoto T; Adachi N
    Medicine (Baltimore); 2021 Oct; 100(41):e27393. PubMed ID: 34731109
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Osteonecrosis of the jaw in a patient on Denosumab.
    Aghaloo TL; Felsenfeld AL; Tetradis S
    J Oral Maxillofac Surg; 2010 May; 68(5):959-63. PubMed ID: 20149510
    [No Abstract]   [Full Text] [Related]  

  • 69. Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy.
    Gille O; Oliveira Bde A; Guerin P; Lepreux S; Richez C; Vital JM
    Spine (Phila Pa 1976); 2012 Mar; 37(6):E396-9. PubMed ID: 22076646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of minimally invasive surgery with standard open surgery for vertebral thoracic metastases causing acute myelopathy in patients with short- or mid-term life expectancy: surgical technique and early clinical results.
    Miscusi M; Polli FM; Forcato S; Ricciardi L; Frati A; Cimatti M; De Martino L; Ramieri A; Raco A
    J Neurosurg Spine; 2015 May; 22(5):518-25. PubMed ID: 25723122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chordoma of the mobile spine: fifty years of experience.
    Boriani S; Bandiera S; Biagini R; Bacchini P; Boriani L; Cappuccio M; Chevalley F; Gasbarrini A; Picci P; Weinstein JN
    Spine (Phila Pa 1976); 2006 Feb; 31(4):493-503. PubMed ID: 16481964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Total en bloc spondylectomy of the eleventh thoracic vertebra following denosumab therapy for the treatment of a giant cell tumor.
    Inoue G; Imura T; Miyagi M; Saito W; Tazawa R; Nakazawa T; Takaso M
    Oncol Lett; 2017 Oct; 14(4):4005-4010. PubMed ID: 28943907
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma.
    Henry DH; Costa L; Goldwasser F; Hirsh V; Hungria V; Prausova J; Scagliotti GV; Sleeboom H; Spencer A; Vadhan-Raj S; von Moos R; Willenbacher W; Woll PJ; Wang J; Jiang Q; Jun S; Dansey R; Yeh H
    J Clin Oncol; 2011 Mar; 29(9):1125-32. PubMed ID: 21343556
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Craniospinal giant cell tumors: clinicoradiological analysis in a series of 11 cases.
    Sharma RR; Mahapatra AK; Pawar SJ; Sousa J; Dev EJ
    J Clin Neurosci; 2002 Jan; 9(1):41-50. PubMed ID: 11749016
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary pyogenic infection of the spine in intravenous drug users: a prospective observational study.
    Wang Z; Lenehan B; Itshayek E; Boyd M; Dvorak M; Fisher C; Kwon B; Paquette S; Street J
    Spine (Phila Pa 1976); 2012 Apr; 37(8):685-92. PubMed ID: 22037525
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary tumors of the cervical spine: a retrospective review of 35 surgically managed cases.
    Zileli M; Kilinçer C; Ersahin Y; Cagli S
    Spine J; 2007; 7(2):165-73. PubMed ID: 17321965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Denosumab: a potential new and innovative treatment option for aneurysmal bone cysts.
    Lange T; Stehling C; Fröhlich B; Klingenhöfer M; Kunkel P; Schneppenheim R; Escherich G; Gosheger G; Hardes J; Jürgens H; Schulte TL
    Eur Spine J; 2013 Jun; 22(6):1417-22. PubMed ID: 23455951
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of risk factors for recurrence of giant cell tumor of the sacrum and mobile spine combined with preoperative embolization.
    Ming Z; Kangwu C; Huilin Y; Genlin W; Jian L; Yiming J; Chunshen W; Chao C
    Turk Neurosurg; 2013; 23(5):645-52. PubMed ID: 24101313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic benefits of neoadjuvant and post-operative denosumab on sacral giant cell tumor: a retrospective cohort study of 30 cases.
    Chen Z; Yang Y; Guo W; Yang R; Tang X; Yan T; Ji T; Xie L; Xu J; Wang J
    J BUON; 2018; 23(2):453-459. PubMed ID: 29745092
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor.
    Iranikhah M; Wilborn TW; Wensel TM; Ferrell JB
    Pharmacotherapy; 2012 Mar; 32(3):274-84. PubMed ID: 22392458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.